← Back to Search

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy for Insomnia and Depression (TIDE Trial)

N/A

Waitlist Available

Led By Kenneth L. Lichstein, Ph.D.

Research Sponsored by University of Alabama, Tuscaloosa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Not currently receiving psychological treatment

50 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month follow-up (23weeks post-treatment)

Awards & highlights

TIDE Trial Summary

This trial is studying whether a combination of therapies can help reduce symptoms of insomnia and depression in adults.

Who is the study for?

The TIDE trial is for rural, African-American adults over 50 with both insomnia and depression. They must not be in current psychological treatment, have a stable mental status (MMSE score ≥24 or ≥17 if education ended at eighth grade), and can't be at serious risk of suicide. Participants need a referral from their primary care doctor within the Black Belt region.Check my eligibility

What is being tested?

This study tests integrated Cognitive Behavioral Therapy (CBT) delivered via videoconferencing to treat insomnia and depression together, compared to usual care alone. It aims to see if this approach is feasible in rural settings and whether it improves sleep quality, mood, and life satisfaction more effectively than standard treatments.See study design

What are the potential side effects?

Since CBT is a non-medical therapy involving talking and behavior change strategies without drugs, side effects are minimal but may include temporary increases in distress as difficult topics are discussed or changes in sleep patterns as new habits form.

TIDE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am not currently undergoing psychological therapy.

Select...

I am 50 years old or older.

TIDE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month follow-up (23weeks post-treatment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month follow-up (23weeks post-treatment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up (23weeks post-treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hamilton Depression Scale

Insomnia Severity Index

Secondary outcome measures

GDS

SOL

WASO

TIDE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CBTExperimental Treatment1 Intervention

Cognitive behavior therapy for both insomnia and depression featuring stimulus control and cognitive therapy.

Group II: Treatment as UsualActive Control1 Intervention

No additional treatment besides regular care.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama, TuscaloosaLead Sponsor

44 Previous Clinical Trials

19,470 Total Patients Enrolled

1 Trials studying Depression

302 Patients Enrolled for Depression

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,689,103 Total Patients Enrolled

665 Trials studying Depression

251,388 Patients Enrolled for Depression

Kenneth L. Lichstein, Ph.D.Principal InvestigatorUniversity of Alabama, Tuscaloosa

Media Library

Integrated Cognitive Behavioral Therapy (CBT) (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT01648049 — N/A

Depression Research Study Groups: CBT, Treatment as Usual

Depression Clinical Trial 2023: Integrated Cognitive Behavioral Therapy (CBT) Highlights & Side Effects. Trial Name: NCT01648049 — N/A

Integrated Cognitive Behavioral Therapy (CBT) (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01648049 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the criteria for becoming a participant in this medical research program?

"This clinical trial is on the lookout for 46 seniors (aged 50-100) with clinically significant depression. In addition to being of a certain age, participants must be residents of the Black Belt area or nearby counties, have an MMSE score of 24+ (17+ if they only completed 8th grade education), not already undergoing psychological treatment, lack any serious suicidal ideation, and have coexisting medical/psychiatric disorders that don't prevent them from attending CBT sessions nor affect data collection. If these individuals are receiving either insomnia or depression medication currently then their primary care physician should still determine if residual symptoms are sufficient enough to warrant further"

Answered by AI

Does this experiment entertain elderly individuals as participants?

"Participation in this study is restricted to those between the ages of 50 and 100. For patients younger than 18, there are 215 trials available, whereas 1,127 studies exist for individuals aged 65 or higher."

Answered by AI

Are there any remaining openings for potential participants in this research?

"The online information on clinicaltrials.gov indicates that recruiting for this trial is not taking place presently, with the initial post having been published on June 1st 2012 and the last update being November 30th 2015. Nevertheless, there are still 1499 other trials actively searching for participants at present."

Answered by AI